---
title: "Verana Health Transforms Site Selection and Patient Enrollment in Clinical Trials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285217308.md"
description: "Verana Health®, a digital health company based in San Francisco, announced on May 5, 2026, that sponsors and CROs will now have exclusive access to enhanced data and functionalities. This update is aimed at speeding up enrollment processes, improving the strength of evidence gathered, and broadening opportunities for patients. The development is significant within the healthcare industry as it will provide crucial support for research and development activities. This updated access is expected to drive faster and more efficient enrollment processes, ultimately benefiting patients, sponsors, and CROs."
datetime: "2026-05-05T13:17:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285217308.md)
  - [en](https://longbridge.com/en/news/285217308.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285217308.md)
---

# Verana Health Transforms Site Selection and Patient Enrollment in Clinical Trials

Verana Health®, a digital health company based in San Francisco, announced on May 5, 2026, that sponsors and CROs will now have exclusive access to enhanced data and functionalities. This update is aimed at speeding up enrollment processes, improving the strength of evidence gathered, and broadening opportunities for patients. The development is significant within the healthcare industry as it will provide crucial support for research and development activities. This updated access is expected to drive faster and more efficient enrollment processes, ultimately benefiting patients, sponsors, and CROs.

### Related Stocks

- [VRNA.US](https://longbridge.com/en/quote/VRNA.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [08:00 ETAvance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership](https://longbridge.com/en/news/286094661.md)
- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)
- [Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis](https://longbridge.com/en/news/286899753.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [BioMarin's drug shows significant growth gains in children in late-stage trial](https://longbridge.com/en/news/287121584.md)